Outcomes of Patients With Esophageal Cancer Staged With [18F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection?

The Impact of Hybrid PET-CT Scan on Overall Oncologic Management, with a Focus on Radiotherapy Planning: A Prospective, Blinded Study

(2014) Tim J. Kruser et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Predictive Value of Initial PET-SUVmax in Patients with Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma

(2010) Nabil P. Rizk et al.   Journal of Thoracic Oncology

[18F]-Fluorodeoxyglucose-Positron Emission Tomography for the Assessment of Histopathologic Response and Prognosis After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer

(2009) Daniel Vallböhmer et al.   ANNALS OF SURGERY

18F-Fluorodeoxiglucose Positron Emission Tomography for the Evaluation of Neoadjuvant Therapy Response in Esophageal Cancer

(2009) Ángel C. Rebollo Aguirre et al.   ANNALS OF SURGERY

Post-treatment Endoscopic Biopsy Is a Poor-Predictor of Pathologic Response in Patients Undergoing Chemoradiation Therapy for Esophageal Cancer

(2009) Inderpal S. Sarkaria et al.   ANNALS OF SURGERY

Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival

(2009) James M. Donahue et al.   ANNALS OF THORACIC SURGERY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma

(2009) Heta Javeri et al.   CANCER

Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer

(2009) Elfriede Bollschweiler et al.   Future Oncology

Does the Value of PET-CT Extend Beyond Pretreatment Staging? An Analysis of Survival in Surgical Patients with Esophageal Cancer

(2009) Boris Sepesi et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response?

(2009) Robert A. Meguid et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer

(2009) Christina T. Muijs et al.   RADIOTHERAPY AND ONCOLOGY

Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis

(2008) E. Bollschweiler et al.   ANNALS OF ONCOLOGY

Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy

(2008) Matthias Schmidt et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Treatment Outcome and Recursive Partitioning Analysis-Based Prognostic Factors in Patients With Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy

(2008) Min Kyoung Kim et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

(2008) Joel Tepper et al.   JOURNAL OF CLINICAL ONCOLOGY

Are Patients with Esophageal Cancer Who Become PET Negative after Neoadjuvant Chemoradiation Free of Cancer?

(2008) James M. McLoughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Metabolic Tumor Width Parameters as Determined on PET/CT Predict Disease-free Survival and Treatment Response in Squamous Cell Carcinoma of the Esophagus

(2008) Johannes B. Roedl et al.   MOLECULAR IMAGING AND BIOLOGY

Adenocarcinomas of the esophagus: Response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET–CT

(2008) Johannes B. Roedl et al.   RADIOTHERAPY AND ONCOLOGY

Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus

(2007) B. M. Smithers et al.   DISEASES OF THE ESOPHAGUS